Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2013	Sep. 23, 2012
Cash flows from operating activities:
Net income	$ 340,705	$ 360,001
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	142,155	144,322
Facility consolidation charges	16,082	14,116
Pension contributions, net of pension expense	(76,251)	(91,917)
Equity income in unconsolidated investees, net	(28,929)	(15,980)
Stock-based compensation – equity awards	23,130	18,108
Change in other assets and liabilities, net	(67,934)	70,086
Net cash flow from operating activities	348,958	498,736
Cash flows from investing activities:
Purchase of property, plant and equipment	(72,668)	(63,010)
Payments for acquisitions, net of cash acquired	(17,527)	(63,344)
Payments for investments	(3,380)	(1,000)
Proceeds from investments	34,779	15,174
Proceeds from sale of a business and other assets	34,336	37,598
Net cash used for investing activities	(24,460)	(74,582)
Cash flows from financing activities:
Proceeds from (payments of) borrowings under revolving credit agreements, net	(205,000)	175,000
Proceeds from (Repayments of) Notes Payable	591,396	(306,571)
Proceeds from issuance of unsecured floating rate term loan	154,800	0
Payments of debt issuance and financing costs	(21,838)	0
Dividends paid	(137,520)	(112,786)
Cost of common shares repurchased	(78,786)	(116,502)
Proceeds from issuance of common stock upon exercise of stock options	15,162	6,606
Distribution to noncontrolling interests	(218)	0
Deferred payments for acquisitions	(6,132)	(1,027)
Net cash from (used for) financing activities	311,864	(355,280)
Effect of currency exchange rate change on cash	(25)	1,645
Increase in cash and cash equivalents	636,337	70,519
Balance of cash and cash equivalents at beginning of period	175,030	166,926
Balance of cash and cash equivalents at end of period	$ 811,367	$ 237,445